Summary
Introduction
Cystic fibrosis (CF) is a recessive disorder affecting about one in 2500 Caucasians. 1 Moreover, it has been recognized as the most lethal genetic disease frequently causing death in children. In Bahrain, previous investigations 2 have shown that the incidence of CF is at least one in 5800 and the prevalence is three in 100 000 population. Moreover, CF in Bahraini children is phenotypically severe; patients have been observed to develop pancreatic insufficiency by the age of 1 year, meconium ileus, and colonization with pseudomonas aeruginosa in addition to the typical presentation of the disease.
Recently, different groups of workers have investigated the mutational patterns of the cystic fibrosis transmembrane regulator (CFTR) gene amongst Arab children, which include patients from Saudi Arabia, [3] [4] [5] Oman, 6 United Arab Emirates, 7 Qatar, 8 and Jordan. 9 Collectively, such work will undoubtedly provide information on the most common mutations in the CFTR gene in the region, thus facilitating the search for a molecular method for the testing of CF in Bahraini patients. Since there was no published data so far to the genotype of those reported cases, the aim of this study was to identify the CFTR gene mutations known to exist in the Bahraini CF population.
Materials and Methods

Patients
Nineteen Bahraini children with CF who belong to 13 unrelated families were the study group who regularly attended the CF clinic at the Department of Pediatrics, Sulmanyia Medical Center in Manama. The diagnosis of CF was made on the basis of the clinical features consistent with a CF phenotype together with an elevated sweat chloride concentration (> 60 mmol/l). The collected clinical data were based on current age, sex, age of onset of symptoms, age at diagnosis, the presence of consanguinity in the parents, and the presence of Pseudomonas aeruginosa lung colonization at the time of diagnosis. Pancreatic insufficiency was diagnosed on the basis of estimating trypsin activity in the stool, in addition to the presence of fat in the stool, and diarrhea, which responded to pancreatic enzyme replacement. However, all patients were counseled and properly advised on the outcome of genetic diagnosis by the attending pediatrician.
Isolation and PCR amplification of genomic DNA Genomic DNA was extracted from leucocytes according to standard procedures. 10 PCR amplification of DNA was performed by preparation of a 50-µl reaction mixture that contained appropriate primers using standard protocols. 4 Mutation analysis All patients were screened for 15 common mutations amongst Arabs by restriction enzyme digestion analysis with appropriate enzymes according to specific protocols 4, 5 and/or using the amplification refractory mutation system (ARMS-PCR) technique. 11 These mutations were: 406-2A→G (intron 3), 425del42 (exon 4), 475G→T (exon 4), 548A→T (exon 4), 1161delC (exon 7), 1548delG (exon10), F508 (exon 10), G542X (exon 11), 2043delG (exon 13), 3120+1G→A (intron 16), 3661A→T (exon 19), 3849+10KbC→T (intron 19), I1234V (exon 19), W1282X (exon 20), and N1303K (exon 21). The obtained DNA fragments were then visualized with ethidium bromide stain and UV transillumination for comparison with those from control samples.
Results
The analyses of specific CFTR mutations in the study group of Bahraini patients on the basis of the DNA fragment sizes, following restriction enzyme digestion are shown in Table 1 . The results also show the diversity and the frequency of the mutations in the Bahraini patients. The study group included 19 patients (12 males and seven females; aged between 4 months and 14 years with a mean age of 5.4 ± 4.3 years). However, nine more sibling patients (five males and four females; equating to 47 per cent of the study group) that belonged to seven different families were not included, as they died at an early age (1-18 months) of cystic fibrosis prior to our study. A total of 13 unrelated families were screened (26 chromosomes) and eight mutations were detected in 21 of the 26 alleles examined (81 per cent). Therefore, the CFTR mutation detection rate among Bahrainis was 81 per cent, a figure comparable to that seen in most populations studied so far. The rate of consanguinity among the families studied was 77 per cent. All families, except two, were of Bahraini origin. One family of Persian origin had three siblings with homozygous mutation for F508. The other family was of Syrian origin, with two siblings who had homozygous mutation for 2043delG. Six families (46 per cent) were homozygous for their respective pathogenic mutations as was expected from the high consanguinity rate in the examined population, whereas six families (46 per cent) were compound heterozygous in which 50 per cent of both mutations were identified. Seven of the eight mutations were reliably detected by PCR-digestion assay. 4, 5 On the other hand, the homozygous mutation F508 was satisfactorily detected using the ARMS-PCR technique (J. Zielenski, personal communication).
The clinical features of our patients ( Table 1) show evidence of severe disease indicated by early age of presentation (< 1-4 months), early colonization with Pseudomonas aeruginosa, pancreatic insufficiency in the first year of life and failure to thrive. Salt depletion episodes were very common in our patients and one of them presented with seizures due to hyponatremia. This was most likely aggravated by the hot climate in Bahrain. However, meconium ileus and cholestasis were not very common in our patients.
Discussion
In our study, it was possible to analyse DNA samples of Bahraini children with CF and their parents for 15 characteristic CFTR mutations, which were identified as common mutations amongst Arabs. 5 Reports on the incidence and prevalence of cystic fibrosis in the Bahraini ethnic population are very limited. 2 The overall distribution of CFTR mutations among Bahrainis in our study differs from what had been reported in the literature so far, for the neighboring Arabian Gulf States. Of the eight mutations detected, four are common among Bahrainis (2043delG > 548A→T > 4041C→G = F508, in order of decreasing frequency), accounting for 66 per cent of the Bahraini CF alleles. Moreover, there was no specific phenotypic pattern that indicated a strong correlation with a specific genotype.
The most frequent (31 per cent) Bahraini mutation 2043delG is not seen, in terms of frequency, in other populations nor, to a certain extent, is the second most frequent (19%) mutation 548A→T. On the other hand, mutation F508, which is the most common mutation in Caucasians, was detected in only one family of Persian origin, accounting for < 8 per cent of the Bahraini CF alleles. However, mutation I1234V, which is specifically the most common mutation amongst neighboring Qatari patients 8 and is generally a common mutation in Arab patients, 5 was not detected in Bahraini patients.
The presence of rare mutations that are encountered more frequently in Bahraini patients with CF supports the possibility that one or more of the mutations investigated in this study, e.g. 548A→T, 2043delG, and 3661A→T, could have originated in this region of the world. Taking into consideration the high rate of consanguinity in the Bahraini population (77 per cent), determination of the genotypes of possible carriers of the defective gene could be particularly useful with respect to genetic counseling of families affected with CF.
When we consider that the 19 Bahraini patients in our study constitute approximately 90 per cent of all CF cases, then the allele frequency of all eight mutations can be estimated to be 73 per cent at a conservative estimate. Further work is obviously needed to identify more mutations in the region in order to validate such a diagnostic procedure.
